Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of Polyepitopic Immunogenic Contrast Against Hepatitis C Virus 1A-6A Genotype by in Silico Approach Publisher



Dehghan Z1, 2 ; Lari A3 ; Yarian F1, 2 ; Ahangarzadeh S4 ; Sharifnia Z2 ; Shahzamani K5 ; Shahidi S2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Cellular & Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Systems Biomedicine, Pasteur Institute of Iran, Iran
  4. 4. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Iran
  5. 5. Isfahan Gastroenterology and Hepatology Research Center (IGHRC), Isfahan University of Medical Sciences, Isfahan, Iran

Source: Biomedical and Biotechnology Research Journal Published:2020


Abstract

Background: Hepatitis C is a viral disease associated with chronic hepatitis and hepatocellular carcinoma. Hepatitis C virus (HCV) plays a critical role in the pathogenesis of this disease. Nonstructural proteins including NS3, NS4A, and NS5A are important in viral replication and translation. Since recent therapies are not appropriate for anti-HCV activity in humans, the main objective of this study is the use of immunoinformatic approaches for designing a novel multiepitope peptide with antigenic properties and examining it as a vaccine against (1a-6a) genotypes of the virus. These types of studies can be helpful for the development of new vaccine strategies against hepatitis C disease. Methods: The conserved position of nonstructural proteins (NS3/NS4a and NS5A) of HCV genotypes was used for vaccine design. Linear and conformational epitopes of B cell, MHC-I, MHC-II binding epitopes, and interferon-gamma inducing epitopes were determined in the construction of the vaccine. Molecular dynamics (MD) simulation and protein docking multiepitope peptides with toll-like receptor (TLR) 3 and TLR8 were analyzed. Results: MD simulation revealed a stable structure of candidate vaccines. Hence, docking results showed multiepitope peptides interaction with TLR3 and TLR8 and epitopes related to NS3 protein have the most interaction. These analyses suggest that designed vaccines can induce humoral and cellular immune responses against HCV. Conclusions: These analyses suggest that designed vaccines can induce humoral and cellular immune responses against HCV. However, experimental tests are required to evaluate the safety and immunogenicity profile of designed multiepitope vaccines. © 2020 Biomedical and Biotechnology Research Journal (BBRJ).
Experts (# of related papers)
Other Related Docs
26. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)